ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,058,000 | +118.4% | 173,911 | +14.9% | 0.01% | +100.0% |
Q1 2019 | $3,689,000 | -35.1% | 151,317 | -62.8% | 0.01% | -40.0% |
Q4 2018 | $5,686,000 | +51.7% | 406,847 | +65.0% | 0.01% | +66.7% |
Q3 2018 | $3,749,000 | +13.5% | 246,627 | +25.3% | 0.01% | +20.0% |
Q2 2018 | $3,303,000 | +2.7% | 196,837 | -0.1% | 0.01% | 0.0% |
Q1 2018 | $3,216,000 | +1132.2% | 197,047 | +868.0% | 0.01% | – |
Q4 2017 | $261,000 | +10.1% | 20,357 | +5.8% | 0.00% | – |
Q3 2017 | $237,000 | +49.1% | 19,247 | +1.5% | 0.00% | – |
Q2 2017 | $159,000 | +2.6% | 18,957 | +9.1% | 0.00% | – |
Q1 2017 | $155,000 | +4.7% | 17,377 | +3.5% | 0.00% | – |
Q4 2016 | $148,000 | +45.1% | 16,787 | +10.6% | 0.00% | – |
Q3 2016 | $102,000 | +100.0% | 15,177 | +6.5% | 0.00% | – |
Q2 2016 | $51,000 | +37.8% | 14,257 | +12.6% | 0.00% | – |
Q1 2016 | $37,000 | -36.2% | 12,657 | -8.0% | 0.00% | – |
Q4 2015 | $58,000 | -7.9% | 13,757 | 0.0% | 0.00% | – |
Q3 2015 | $63,000 | -36.4% | 13,757 | 0.0% | 0.00% | – |
Q2 2015 | $99,000 | -2.9% | 13,757 | -0.7% | 0.00% | – |
Q1 2015 | $102,000 | +92.5% | 13,857 | +23.1% | 0.00% | – |
Q4 2014 | $53,000 | +29.3% | 11,257 | -0.9% | 0.00% | – |
Q3 2014 | $41,000 | -59.4% | 11,357 | -48.9% | 0.00% | – |
Q2 2014 | $101,000 | +90.6% | 22,226 | +95.7% | 0.00% | – |
Q1 2014 | $53,000 | -8.6% | 11,357 | -1.7% | 0.00% | – |
Q4 2013 | $58,000 | -19.4% | 11,557 | 0.0% | 0.00% | – |
Q3 2013 | $72,000 | +44.0% | 11,557 | +4.5% | 0.00% | – |
Q2 2013 | $50,000 | – | 11,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MUFG Americas Holdings Corp | 36,200 | $71,000 | 0.00% |